EyePoint CMO Ramiro Ribeiro Liquidates Full Shareholding in Recent Transaction
Ramiro Ribeiro, the Chief Medical Officer of EyePoint Pharmaceuticals (NASDAQ:EYPT), executed a transaction on June 30, 2026, resulting in the complete liquidation of his direct common stock holdings. The executive disposed of 4,875 shares, which were acquired through the exercise of previously vested options, generating proceeds of approximately $…